Cargando…

Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation

BACKGROUND: Preoperative inflammatory status plays an important role in the prognosis of malignancy. We sought to explore the value of preoperative inflammatory biomarkers in predicting long-term outcomes of liver transplantation (LT) in patients with hepatocellular carcinoma (HCC). METHOD: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Songping, Cao, Shuang, Chen, Qing, He, Qiang, Lang, Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083266/ https://www.ncbi.nlm.nih.gov/pubmed/37051235 http://dx.doi.org/10.3389/fimmu.2023.1118053

Ejemplares similares

Therapeutically targeting essential metabolites to improve immunometabolism manipulation after liver transplantation for hepatocellular carcinoma
por: Zhang, Wenhui, et al.
Publicado: (2023)

Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016)

The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease
por: Ren, Bin, et al.
Publicado: (2021)

The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation
por: Jiang, Tao, et al.
Publicado: (2021)

Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Kornberg, Arno, et al.
Publicado: (2022)

Prognostic value of combined preoperative fibrinogen and neutrophil–lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016)

Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis
por: Sun, Xiao-Dong, et al.
Publicado: (2016)

A preoperative nomogram predicts prognosis of patients with hepatocellular carcinoma after liver transplantation: a multicenter retrospective study
por: Huang, Dabing, et al.
Publicado: (2021)

Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma
por: Ju, Feng, et al.
Publicado: (2023)

Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
por: Ding, Lei, et al.
Publicado: (2022)

Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
por: Lam, Jian Hang, et al.
Publicado: (2019)

Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation
por: Chen, Zhitao, et al.
Publicado: (2020)

Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma
por: Zheng, Jianxiong, et al.
Publicado: (2023)

Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
por: Jiang, Jingyu, et al.
Publicado: (2023)

Prognostic Value of Preoperative Serum Leucine Aminopeptidases in Hepatocellular Carcinoma Patients Who Underwent Liver Transplantation
por: Ren, Qingqi, et al.
Publicado: (2021)

Prognostic Significance of Preoperative Integrated Liver Inflammatory Score in Patients with Hepatocellular Carcinoma
por: Wu, Biao, et al.
Publicado: (2022)

Preoperative immune landscape predisposes adverse outcomes in hepatocellular carcinoma patients with liver transplantation
por: Yoon, Sang-Ho, et al.
Publicado: (2021)

Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
por: Hong, Ting, et al.
Publicado: (2022)

Incidental Hepatocellular Carcinoma after Liver Transplantation: Clinicopathologic Features and Prognosis
por: Ozdemir, Fatih, et al.
Publicado: (2022)

Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation
por: Wang, Yangyang, et al.
Publicado: (2023)

Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review
por: Qiao, Zi-yun, et al.
Publicado: (2021)

Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature
por: Zhang, Ze, et al.
Publicado: (2022)

Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy
por: Lee, Kyuho, et al.
Publicado: (2017)

Incidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver Transplantation
por: El Moghazy, Walid, et al.
Publicado: (2016)

Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy
por: Wu, YiFeng, et al.
Publicado: (2021)

Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma
por: Wenpei, Guo, et al.
Publicado: (2023)

Preoperative serum hepatitis B virus DNA was a risk factor for hepatocellular carcinoma recurrence after liver transplantation
por: Zhang, Dali, et al.
Publicado: (2022)

Preoperative systemic inflammatory response index predicts long-term outcomes in type B aortic dissection after endovascular repair
por: Zhao, Yufei, et al.
Publicado: (2022)

Liver Transplantation for Hepatocellular Carcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2008)

CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma
por: Chen, Lin, et al.
Publicado: (2021)

Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
por: Zhang, Zhen, et al.
Publicado: (2022)

Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging
por: Chen, Yidi, et al.
Publicado: (2022)

Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection
por: Gao, Xing-hui, et al.
Publicado: (2017)

Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved Prognosis in Patients With Hepatocellular Carcinoma
por: Li, Hui, et al.
Publicado: (2021)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Yan, Zongcai, et al.
Publicado: (2021)

A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses
por: Cai, Guangzhen, et al.
Publicado: (2022)

Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma
por: Yu, Hongjun, et al.
Publicado: (2022)

Implications of m6A-associated snRNAs in the prognosis and immunotherapeutic responses of hepatocellular carcinoma
por: Zhang, Cheng, et al.
Publicado: (2022)

Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma
por: Cheng, Qianqian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s36f16lu1ppom0eb5dq0bs9vpq